Healthy Extracts Inc. acquires Adli Gummies Inc. (2026)

Deal facts

Buyer: Healthy Extracts Inc.
Target: Adli Gummies Inc.
Deal value: Not disclosed
Announced: 15 May 2026
Status: Completed
Sector: Healthcare
Country: Canada
Consideration: shares, loan-note

Sources

What we know

Healthy Extracts Inc. has agreed to acquire Adli Gummies Inc. in a strategic acquisition within the Healthcare sector. The transaction was announced and completed on 15 May 2026, with consideration structured through a combination of shares and loan notes. The buyer is based in the United States, while the target operates from Canada. No specific deal value was disclosed in the available records.

The deal represents a cross-border consolidation between two entities in the health and wellness space. The transaction has been finalised, marking the immediate transfer of ownership from the target to the acquiring company. Regulatory approvals were secured as part of the closing process, allowing the combined entity to proceed with its integrated operations without further delay.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update

15 May 2026CompletedClosed
Healthy Extracts Inc. completes acquisition of Adli Gummies Inc.
Item 1.01 Entry into a Material Definitive Agreement. Acquisition of Adli Gummies Inc. and the Imaraïs Beauty Brand On May 15, 2026, we entered into an Acquisition Agreement (the “Acquisition Agreement”) with Adli Gummies Inc., an Ontario corporation which does business as Imaraïs Beauty (“Adli”), and its shareholders. Pursuant to the Acquisition Agreement, through our wholly-owned subsidiary Heal
Source

OpinionExit Mode editorial

We see a clear signal in the cross-border movement of Healthy Extracts Inc acquiring Adli Gummies Inc. This completed strategic acquisition moves a Canadian target into US ownership within the healthcare sector. The deal structure is particularly instructive for the SME founder navigating international expansion. By opting for shares and a loan note rather than a clean cash exit, the parties have aligned their long-term interests while deferring immediate tax liabilities. This is a common mechanic when buyers seek to preserve cash or when sellers wish to maintain an economic stake in the future success of the combined entity.

The choice of consideration type often reflects the regulatory and commercial realities of the transaction. In a cross-border deal between the US and Canada, the use of loan notes can serve as a bridge for financing gaps or as a tool to manage currency risk. It also suggests that the buyer, Healthy Extracts Inc, may have preferred to keep capital within the business to fund integration or further growth rather than draining liquidity for a full cash payout. For the SME founder, this structure demands a clear understanding of how the loan note will be serviced and what rights attach to the shares received. Without a cash lump sum, the founder remains exposed to the operational performance of the new group.

Regulatory clearance in such transactions often hinges on competition thresholds and change-of-control covenants. While the deal is already completed, the mechanics imply that both parties navigated the necessary antitrust reviews and secured the required approvals from relevant authorities in both jurisdictions. The absence of a disclosed value does not diminish the strategic intent. It highlights a shift towards asset consolidation in the health and wellness space, where product portfolios and brand equity are being aggregated by larger players. We think this trend will continue as larger entities seek to diversify their offerings through targeted bolt-on acquisitions.

The immediate lesson for the SME founder is to scrutinise the service terms of any loan note before signing. Do not assume the note will be paid out on a fixed date without conditions. You must verify the specific covenants that could trigger an early repayment or a conversion into additional equity if the buyer's performance dips. Ask your legal team to model the worst-case scenario for the loan note repayment schedule this week.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Healthcare deals More 2026 deals More strategic acquisition deals More from Healthy Extracts Inc.All M&A deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Not statedCompletedHealthcare

Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited

Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…

Buyer: Circle Health Holdings Limited
Target: CHC Healthcare Holdings Limited
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United Kingdom deals

15 July 2026CompletedHealthcare

GSK plc to acquire Nuvalent, Inc

GSK plc has agreed to acquire Nuvalent, Inc in a strategic acquisition valued at $10.6 billion. The transaction, announced and completed on 15 July 2026, involves full c…

Buyer: GSK plc
Target: Nuvalent, Inc
Deal value: USD 10,600,000,000
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United States deals

14 July 2026CompletedHealthcare

Volex plc to acquire Kepler SignalTek Ltd

Volex plc has agreed to acquire Kepler SignalTek Ltd, a healthcare sector business based in the United Kingdom. The strategic acquisition was announced and completed on…

Buyer: Volex plc
Target: Kepler SignalTek Ltd
Deal value: USD 89,400,000
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United Kingdom deals

2 July 2026CompletedHealthcare

Lixte Biotechnology Holdings, Inc. to acquire Nomad Transportable Power Systems, Inc.

Lixte Biotechnology Holdings, Inc. has agreed to acquire Nomad Transportable Power Systems, Inc. in a strategic acquisition within the Healthcare sector. The transaction…

Buyer: Lixte Biotechnology Holdings, Inc.
Target: Nomad Transportable Power Systems, Inc.
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United States deals

30 June 2026Firm intentionHealthcare

Public Company Management Corporation to acquire Physicians Capital Management Corporation

Public Company Management Corporation has agreed to acquire Physicians Capital Management Corporation in a strategic acquisition within the healthcare sector. The transa…

Buyer: Public Company Management Corporation
Target: Physicians Capital Management Corporation
Deal value: Not disclosed
Deal type: strategic acquisition

Read deal Healthcare deals strategic acquisition deals United States deals

Buyer history